4//SEC Filing
Midatech Pharma US Inc. 4
Accession 0001354488-15-005383
CIK 0000919745operating
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 7:38 AM ET
Size
14.2 KB
Accession
0001354488-15-005383
Insider Transaction Report
Form 4
Benharris David
Senior Vice President
Transactions
- Disposition to Issuer
Stock Option
2015-12-04−10,000→ 0 totalExercise: $5.00From: 2015-12-04Exp: 2022-05-15→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−95,000→ 0 totalExercise: $0.79From: 2015-12-04Exp: 2025-02-09→ Common Stock (95,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−30,000→ 0 totalExercise: $2.90From: 2015-12-04Exp: 2024-03-04→ Common Stock (30,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−35,000→ 0 totalExercise: $5.05From: 2015-12-04Exp: 2023-02-28→ Common Stock (35,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−35,000→ 0 totalExercise: $0.69From: 2019-05-19Exp: 2025-05-19→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]In connection with the closing of the Agreement and Plan of Merger among DARA BioSciences, Inc. (DARA), Midatech Pharma PLC (Midatech) and certain other parties thereto, these options were assumed by Midatech and replaced with options to purchase 0.136 Midatech American Depository Receipts (Midatech ADRs) for each DARA option held, at an exercise price equal to the exercise price of the applicable DARA option divided by 0.136. Each Midatech ADR represents two Midatech ordinary shares.
Documents
Issuer
Midatech Pharma US Inc.
CIK 0000919745
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000919745
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 7:38 AM ET
- Size
- 14.2 KB